The microbiology of human hygiene and its impact on type 1 diabetes

Islets

Volumn 4, Issue 4, 2012, Pages 253-261

  Chapman, Nora M ^a   Coppieters, Ken ^b   Von Herrath, Matthias ^c   Tracy, Steven ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoimmunity; Bacteria; Enterovirus; Environment; Hygiene; Microbiology

Indexed keywords

EID: 84868100525     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.21570     Document Type: Review

References (119)

1. Sanders LJ. From Thebes to Toronto and the 21st Century: An Incredible Journey. Diabetes Spectrum 2002; 15:56-60; http://dx.doi.org/10.2337/diaspect. 15.1.56.
2. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008; 371:1777-82; PMID:18502302; http://dx.doi.org/10.1016/S0140-6736(08)60765-5. (Pubitemid 351697953)
3. Viskari HR, Koskela P, Lönnrot M, Luonuansuu S, Reunanen A, Baer M, et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 2000; 23:414-6; PMID:10868874; http://dx.doi.org/10. 2337/diacare.23.3.414. (Pubitemid 30131753)
4. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51:3353-61; PMID:12453886; http://dx.doi.org/10.2337/diabe-tes. 51.12.3353. (Pubitemid 35403436)
5. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703-7; PMID:19430480; http://dx.doi.org/10.1038/ng.381.
6. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32:457-67; PMID:20412756; http://dx.doi.org/10.1016/j.immuni.2010.04.001.
7. Ziegler AG, Nepom GT. Prediction and pathogen-esis in type 1 diabetes. Immunity 2010; 32:468-78; PMID:20412757; http://dx.doi.org/10.1016/j.immu-ni. 2010.03.018.
8. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field S F, Stevens HE, et al.; Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450:887-92; PMID:18004301; http://dx.doi.org/10.1038/nature06406. (Pubitemid 350231332)
9. Knip M. Pathogenesis of type 1 diabetes: implications for incidence trends. Horm Res Paediatr 2011; 76(Suppl 1):57-64; PMID:21778751; http://dx.doi.org/10.1159/000329169.
10. Drescher KM, Tracy SM. The CVB and etiology of type 1 diabetes. Curr To p Microbiol Immunol 2008; 323:259-74; PMID:18357774; http://dx.doi.org/10.1007/ 978-3-540-75546-3-12.
11. Renz H, Autenrieth IB, Brandtzæg P, Cookson WO, Holgate S, von Mutius E, et al. Gene-environment interaction in chronic disease: a European Science Foundation Forward Look. J Allergy Clin Immunol 2011; 128(Suppl):S27-49; PMID:22118218; http://dx.doi.org/10.1016/j.jaci.2011.09.039.
12. Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am 2005; 52:1553-78; PMID:16301083; http://dx.doi.org/10.1016/j.pcl.2005.07.006. (Pubitemid 41654729)
13. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001; 44:354-62; PMID:11317668; http://dx.doi.org/10.1007/s001250051626. (Pubitemid 32234463)
14. Staines A, Bodansky HJ, McKinney PA, Alexander FE, McNally RJ, Law GR, et al. Small area variation in the incidence of childhood insulin-dependent diabetes mellitus in Yorkshire, UK: links with overcrowding and population density. Int J Epidemiol 1997; 26:1307-13; PMID:9447411; http://dx.doi.org/10. 1093/ije/26.6.1307. (Pubitemid 28010449)
15. Patterson CC, Carson DJ, Hadden DR; Northern Ireland Diabetes Study Group. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Diabetologia 1996; 39:1063-9; PMID:8877290; http://dx.doi.org/10.1007/ BF00400655. (Pubitemid 26275936)
16. LaPorte RE, Fishbein HA, Drash AL, Kuller LH, Schneider BB, Orchard TJ, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mel-litus in Allegheny County, Pennsylvania (1965-1976). Diabetes 1981; 30:279-84; PMID:7202862; http://dx.doi.org/10.2337/diabetes.30.4.279. (Pubitemid 11022513)
17. Karvonen M, Tuomilehto J, Libman I, LaPorte R; World Health Organization DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:883-92; PMID:8243865; http://dx.doi.org/10.1007/ BF02374468. (Pubitemid 23288746)
18. Colle E, Siemiatychi J, West R, Belmonte M, Crepeau M, Poirier R, et al. Incidence of juvenile onset diabetes in Montreal-demonstration of ethnic and socio-economic class differences. J Chronic Dis 1981; 34:611-6; PMID:7309825; http://dx.doi.org/10.1016/0021-9681(81)90060-6. (Pubitemid 12237537)
19. Cherubini V, Carle F, Gesuita R, Iannilli A, Tuomilehto J, Prisco F, et al. Large incidence variation of Type I diabetes in central-southern Italy 1990-1995: lower risk in rural areas. Diabetologia 1999; 42:789-92; PMID:10440119; http://dx.doi.org/10.1007/s001250051228. (Pubitemid 29325067)
20. D'Angeli MA, Merzon E, Valbuena L F, Tirschwell D, Paris CA, Mueller BA. Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses. Arch Pediatr Adolesc Med 2010; 164:732-8; PMID:20679164; http://dx.doi.org/10.1001/archpe-diatrics.2010. 115.
21. Karvonen M, Tuomilehto J, Libman I, LaPorte R; World Health Organization DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:883-92; PMID:8243865; http://dx.doi.org/10.1007/ BF02374468. (Pubitemid 23288746)
22. Steck AK, Armstrong TK, Babu SR, Eisenbarth GS; Type 1 Diabetes Genetics Consortium. Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes 2011; 60:1045-9; PMID:21307077; http://dx.doi.org/10.2337/db10-1419.
23. Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008; 31:1546-9; PMID:18487476; http://dx.doi.org/10.2337/dc08-0239.
24. Vehik K, Hamman R F, Lezotte D, Norris JM, Klingensmith GJ, Rewers M, et al. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 2008; 31:1392-6; PMID:18356404; http://dx.doi.org/10. 2337/dc07-2210.
25. Hermann R, Knip M, Veijola R, Simell O, Laine A P, Akerblom HK, et al.; FinnDiane Study Group. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure? Diabetologia 2003; 46:420-5; PMID:12687342. (Pubitemid 36547599)
26. Witas H W, Jedrychowska-Danska K, Zawicki P. Changes in frequency of IDDM-associated HLA DQB, CTLA4 and INS alleles. Int J Immunogenet 2010; 37:155-8; PMID:20345871; http://dx.doi.org/10.1111/j.1744-313X.2010.00896.x.
27. Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 2012; 42:5-15; PMID:22090147; http://dx.doi.org/10.1007/s12016-011-8285- 8.
28. Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, et al.; RIDI Study Group. Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes 2010; 59:2281-7; PMID:20566665; http://dx.doi.org/10.2337/db10-0151.
29. Aamodt G, Stene LC, Njølstad PR, Søvik O, Joner G; Norwegian Childhood Diabetes Study Group. Spatiotemporal trends and age-period-cohort modeling of the incidence of type 1 diabetes among children aged <15 years in Norway 1973-1982 and 1989-2003. Diabetes Care 2007; 30:884-9; PMID:17392550; http://dx.doi.org/10.2337/dc06-1568. (Pubitemid 46556582)
30. Lönnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S, et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000; 49:1314-8; PMID:10923631; http://dx.doi.org/10. 2337/diabe-tes.49.8.1314.
31. Andréoletti L, Hober D, Hober-Vandenberghe C, Belaich S, Vantyghem MC, Lefebvre J, et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997; 52:121-7; PMID:9179756; http://dx.doi.org/10.1002/(SICI)1096- 9071(199706)52:23.0.CO;2-5. (Pubitemid 27239308)
32. Sarmiento L, Cabrera-Rode E, Lekuleni L, Cuba I, Molina G, Fonseca M, et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 2007; 40:540-5; PMID:17966045; http://dx.doi.org/10.1080/08916930701523429. (Pubitemid 351233176)
33. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-51; PMID:19266182; http://dx.doi.org/10.1007/s00125-009-1276-0.
34. Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr To p Microbiol Immunol 2008; 323:275-92; PMID:18357775; http://dx.doi.org/10.1007/ 978-3-540-75546-3-13.
35. Tracy S, Chapman NM, McManus BM, Pallansch MA, Beck MA, Carstens J. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 1990; 22:403-14; PMID:2167382; http://dx.doi.org/10.1016/0022-2828(90)91476-N. (Pubitemid 20195700)
36. Chapman NM, Kim KS, Drescher KM, Oka K, Tracy S. 5' terminal deletions in the genome of a coxsacki-evirus B2 strain occurred naturally in human heart. Virology 2008; 375:480-91; PMID:18378272; http://dx.doi.org/10.1016/j.virol. 2008.02.030.
37. Kim KS, Chapman NM, Tracy S. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J Virol 2008; 82:2033-7; PMID:18057248; http://dx.doi.org/10.1128/JVI.01774-07. (Pubitemid 351206949)
38. Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, et al. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 2005; 79:7024-41; PMID:15890942; http://dx.doi.org/10.1128/ JVI.79.11.7024-7041.2005. (Pubitemid 40677334)
39. van der Werf N, Kroese FG, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007; 23:169-83; PMID:17103489; http://dx.doi.org/10.1002/dmrr.695. (Pubitemid 46437842)
40. Bach J F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-20; PMID:12239261; http://dx.doi.org/10.1056/NEJMra020100.
41. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011; 6:e25792; PMID:22043294; http://dx.doi.org/10.1371/journal.pone.0025792.
42. Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010; 5:e10507; PMID:20463897; http://dx.doi.org/10.1371/ journal.pone.0010507.
43. Neu J, Lorca G, Kingma SD, Triplett EW. The intestinal microbiome: relationship to type 1 diabetes. Endocrinol Metab Clin North Am 2010; 39:563-71; PMID:20723820; http://dx.doi.org/10.1016/j.ecl.2010.05.008.
44. Roesch L F, Lorca GL, Casella G, Giongo A, Naranjo A, Pionzio AM, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009; 3:536-48; PMID:19225551; http://dx.doi.org/10.1038/ismej.2009.5.
45. King C, Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 2011; 6:e17049; PMID:21364875; http://dx.doi.org/10.1371/journal.pone.0017049.
46. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-62; PMID:18820210; http://dx.doi.org/10.2337/db08-0331.
47. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5:601-4; PMID:10371488; http://dx.doi.org/10.1038/ 9442. (Pubitemid 29289413)
48. Strachan D P. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-60; PMID:2513902; http://dx.doi.org/10.1136/bmj.299.6710.1259. (Pubitemid 19280051)
49. Tracy S, Drescher KM, Jackson JD, Kim K, Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010; 20:106-16; PMID:20049905; http://dx.doi.org/10.1002/rmv.639.
50. Okada H, Kuhn C, Feillet H, Bach J F. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160:1-9; PMID:20415844; http://dx.doi.org/10.1111/j.1365-2249.2010.04139.x.
51. An PG. Constructing and dismantling frameworks of disease etiology: the rise and fall of sewer gas in America 1870-1910. Yale J Biol Med 2004; 77: 75-100; PMID:15829149. (Pubitemid 44387535)
52. Halliday S. Death and miasma in Victorian London: an obstinate belief. BMJ 2001; 323:1469-71; PMID:11751359; http://dx.doi.org/10.1136/bmj.323.7327. 1469. (Pubitemid 34025218)
53. Delaporte F. Disease and Civilization: The Cholera in Paris, 1832. Cambridge, MA: The MIT Press, 1989.
54. Cantalupo PG, Calgua B, Zhao G, Hundesa A, Wier AD, Katz J P, et al. Raw sewage harbors diverse viral populations. MBio 2011; 2; PMID:21972239; http://dx.doi.org/10.1128/mBio.00180-11.
55. Nathanson N, Martin JR. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epi-demicity, and disappearance. Am J Epidemiol 1979; 110:672-92; PMID:400274.
56. Bunimovich-Mendrazitsky S, Stone L. Modeling polio as a disease of development. J Theor Biol 2005; 237:302-15; PMID:15975604; http://dx.doi.org/10. 1016/j.jtbi.2005.04.017. (Pubitemid 41476458)
57. Paul JR. A History of Poliomyelitis. Yale University Press, 1978.
58. Horstmann DM. The poliomyelitis story: a scientific hegira. Yale J Biol Med 1985; 58:79-90; PMID:2994307. (Pubitemid 15031218)
59. Modlin J F. Poliomyelitis and poliovirus immunization. In: Rotbart HA, ed. Human Enterovirus Infections. Washington, D.C.: ASM Press, 1995:195-220.
60. Minor PD. Poliovirus. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia: Lippincott-Raven, 1996:555-74.
61. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010; 172:1213-29; PMID:20978089; http://dx.doi.org/10.1093/aje/kwq320.
62. Horstmann DM. Poliomyelitis: severity and type of disease in different age groups. Ann N Y Acad Sci 1955; 61:956-67; PMID:13340604; http://dx.doi.org/10.1111/j.1749-6632.1955.tb42554.x.
63. Fales W T, Taback M. Observations on the epidemiology of poliomyelitis. Public Health Rep 1952; 67:47-52; PMID:14883288; http://dx.doi.org/10.2307/ 4587979.
64. Nathanson N, McGann KA, Wilesmith J, Desrosiers RC, Brookmeyer R. The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res 1993; 29:3-20; PMID:8212850; http://dx.doi.org/10.1016/0168-1702(93)90122-4. (Pubitemid 23214880)
65. Nathanson N, Murphy FA. Evolution of viral diseases. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia: Lippincott-Raven, 1996:353-70.
66. Pallansch M, Roos R. Enteroviruses: Polioviruses, cox-sackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, ed. Fields Virology. Philadelphia: Wolters Kluwer, 2007:839-94.
67. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23:1516-26; PMID:11023146; http://dx.doi.org/10.2337/diacare.23.10.1516.
68. Padaiga Z, Tuomilehto J, Karvonen M, Podar T, Brigis G, Urbonaite B, et al. Incidence trends in childhood onset IDDM in four countries around the Baltic sea during 1983-1992. Diabetologia 1997; 40:187-92; PMID:9049479; http://dx.doi.org/10.1007/s001250050661. (Pubitemid 27060291)
69. Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005; 48:1280-7; PMID:15902401; http://dx.doi.org/10.1007/s00125-005-1780-9. (Pubitemid 41186091)
70. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004; 4:989-97; PMID:15573133; http://dx.doi.org/10.1038/nri1502. (Pubitemid 39620073)
71. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002; 76:12097-111; PMID:12414951; http://dx.doi.org/10.1128/JVI.76.23.12097-12111.2002. (Pubitemid 35304309)
72. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004; 329:381-94; PMID:15518817; http://dx.doi.org/10.1016/j.virol.2004.06.049. (Pubitemid 39423987)
73. Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 2006; 80:5637-43; PMID:16699045; http://dx.doi.org/10.1128/JVI.02361-05.
74. Pevear DC, Oh CK, Cunningham LL, Calenoff M, Jubelt B. Localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain W-2. J Gen Virol 1990; 71:43-52; PMID:2154539; http://dx.doi.org/10.1099/ 0022-1317-71-1-43. (Pubitemid 20046008)
75. Couderc T, Guinguene B, Horaud F, Aubert-Combiescu A, Crainic R. Molecular pathogenesis of type 2 poliovirus in mice. Eur J Epidemiol 1989; 5:270-4; PMID:2551721; http://dx.doi.org/10.1007/BF00144825. (Pubitemid 19238236)
76. Racaniello VR. One hundred years of poliovirus patho-genesis. Virology 2006; 344:9-16; PMID:16364730; http://dx.doi.org/10.1016/j.virol.2005.09.015. (Pubitemid 41814444)
77. Racaniello VR, Ren R. Transgenic mice and the patho-genesis of poliomyelitis. Arch Virol Suppl 1994; 9:79-86; PMID:8032284.
78. Liu W, Huber SA. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response. Virol J 2011; 8:32; PMID:21255407; http://dx.doi.org/10.1186/1743-422X-8-32.
79. Gauntt C, Huber S. Coxsackievirus experimental heart diseases. Front Biosci 2003; 8:e23-35; PMID:12456330; http://dx.doi.org/10.2741/928.
80. Olszak T, An D, Zeissig S, Vera M P, Richter J, Franke A, et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function. Science (New York, NY) 2012.
81. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio C W, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478:250-4; PMID:21937990; http://dx.doi.org/10.1038/nature10434.
82. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 2011; 108:11548-53; PMID:21709219; http://dx.doi.org/10.1073/pnas.1108924108.
83. Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91; PMID:20613793; http://dx.doi.org/10.1038/ismej.2010.92.
84. Björkstén B. The hygiene hypothesis: do we still believe in it? Nestle Nutr Workshop Ser Pediatr Program 2009; 64:11-8, discussion 18-22, 251-7; PMID:19710512; http://dx.doi.org/10.1159/000235780.
85. Froeschle JE, Feorino PM, Gelfand HM. A continuing surveillance of enterovirus infection in healthy children in six United States cities. II. Surveillance enterovirus isolates 1960-1963 and comparison with enterovirus isolates from cases of acute central nervous system disease. Am J Epidemiol 1966; 83:455-69; PMID:5932697.
86. Roep BO, Atkinson M. Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 2004; 47:1650-6; PMID:15490110; http://dx.doi.org/10.1007/s00125-004-1517-1. (Pubitemid 40022396)
87. In't Veld P. Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 2011; 3:131-8; PMID:21606672; http://dx.doi.org/10.4161/isl.3.4. 15728.
88. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 2011; 54:2417-20; PMID:21597997; http://dx.doi.org/10.1007/s00125-011-2192-7.
89. Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann N Y Acad Sci 2007; 1103:143-51; PMID:17376828; http://dx.doi.org/10.1196/annals.1394.009. (Pubitemid 46791110)
90. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003; 1:151-7; PMID:15035044; http://dx.doi.org/10.1038/nrmi-cro754.
91. Berger CN, Sodha SV, Shaw RK, Griffin PM, Pink D, Hand P, et al. Fresh fruit and vegetables as vehicles for the transmission of human pathogens. Environ Microbiol 2010; 12:2385-97; PMID:20636374; http://dx.doi.org/10.1111/j. 1462-2920.2010.02297.x.
92. Lynch MF, Tauxe RV, Hedberg CW. The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities. Epidemiol Infect 2009; 137:307-15; PMID:19200406; http://dx.doi.org/10.1017/S0950268808001969.
93. Heaton JC, Jones K. Microbial contamination of fruit and vegetables and the behaviour of enteropatho-gens in the phyllosphere: a review. J Appl Microbiol 2008; 104:613-26; PMID:17927745; http://dx.doi.org/10.1111/j.1365- 2672.2007.03587.x. (Pubitemid 351257730)
94. Sivapalasingam S, Friedman CR, Cohen L, Tauxe RV. Fresh produce: a growing cause of outbreaks of food-borne illness in the United States, 1973 through 1997. J Food Prot 2004; 67:2342-53; PMID:15508656. (Pubitemid 39412251)
95. Matricardi PM, Bonini S. Mimicking microbial 'education' of the immune system: a strategy to revert the epidemic trend of atopy and allergic asthma? Respir Res 2000; 1:129-32; PMID:11667975; http://dx.doi.org/10.1186/rr22.
96. Muegge BD, Kuczynski J, Knights D, Clemente JC, González A, Fontana L, et al. Diet drives convergence in gut microbiome functions across mammalian phy-logeny and within humans. Science 2011; 332:970-4; PMID:21596990; http://dx.doi.org/10.1126/sci-ence.1198719.
97. Witsø E, Cinek O, Aldrin M, Grinde B, Rasmussen T, Wetlesen T, et al. Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study. Int J Epidemiol 2010; 39:459-68; PMID:19939809; http://dx.doi.org/10.1093/ije/dyp333.
98. Penders J, Thijs C, Vink C, Stelma F F, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511-21; PMID:16882802; http://dx.doi.org/10.1542/ peds.2005-2824. (Pubitemid 46085405)
99. Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 2007; 622:58-69; PMID:17612575; http://dx.doi.org/10.1016/j.mrfm-mm.2007.03.011. (Pubitemid 47211174)
100. Schwartz R F, Neu J, Schatz D, Atkinson MA, Wasserfall C. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108. Diabetologia 2007; 50:220-1; PMID:17119915; http://dx.doi.org/10.1007/s00125-006-0526-7. (Pubitemid 46035873)
101. Brugman S, Klatter FA, Visser JT, Wildeboer-Veloo AC, Harmsen HJ, Rozing J, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49:2105-8; PMID:16816951; http://dx.doi.org/10.1007/s00125-006-0334-0. (Pubitemid 44168478)
102. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010; 107:12204-9; PMID:20566854; http://dx.doi.org/10.1073/pnas.0909122107.
103. Wingender G, Stepniak D, Krebs P, Lin L, McBride S, Wei B, et al. Intestinal microbes affect pheno-types and functions of invariant natural killer T cells in mice. Gastroenterology 2012; 143:418-28; PMID:22522092; http://dx.doi.org/10.1053/j.gas-tro.2012.04.017.
104. Romano-Keeler J, Weitkamp JH, Moore DJ. Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes. Curr Opin Endocrinol Diabetes Obes 2012; 19:73-80; PMID:22357099.
105. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012; 13:260-70; PMID:22411464.
106. Petrovsky N. Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nat Rev Endocrinol 2010; 6:131-8; PMID:20173774; http://dx.doi.org/10.1038/nrendo.2009.273.
107. Boerner B P, Sarvetnick NE. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann N Y Acad Sci 2011; 1243:103-18; PMID:22211896; http://dx.doi.org/10.1111/j.1749-6632.2011.06340.x.
108. Juhela S, Hyöty H, Roivainen M, Härkönen T, Putto-Laurila A, Simell O, et al. T-cell responses to enterovi-rus antigens in children with type 1 diabetes. Diabetes 2000; 49:1308-13; PMID:10923630; http://dx.doi.org/10. 2337/diabetes.49.8.1308. (Pubitemid 30624230)
109. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009; 119:1515-23; PMID:19478458.
110. Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 2005; 54:1546-52; PMID:15987795; http://dx.doi.org/10.1136/gut.2004.059451. (Pubitemid 41531769)
111. Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-39; PMID:14727023; http://dx.doi.org/10.1007/s00125-003-1297-z. (Pubitemid 38315359)
112. Smura T, Ylipaasto P, Klemola P, Kaijalainen S, Kyllönen L, Sordi V, et al. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol 2010; 82:1940-9; PMID:20872722; http://dx.doi.org/10.1002/jmv.21894.
113. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355-9; PMID:16741115; http://dx.doi.org/10.1126/sci-ence.1124234. (Pubitemid 43839542)
114. Sekirov I, Finlay BB. Human and microbe: united we stand. Nat Med 2006; 12:736-7; PMID:16829917; http://dx.doi.org/10.1038/nm0706-736. (Pubitemid 44050051)
115. Goodacre R. Metabolomics of a superorganism. J Nutr 2007; 137(Suppl):259S-66S; PMID:17182837. (Pubitemid 46070106)
116. Shaw SY, Blanchard J F, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010; 105:2687-92; PMID:20940708; http://dx.doi.org/10.1038/ ajg.2010.398.
117. Ajslev TA, Andersen CS, Gamborg M, Sørensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-preg-nancy weight and early administration of antibiotics. Int J Obes (Lond) 2011; 35:522-9; PMID:21386800; http://dx.doi.org/10.1038/ijo.2011.27.
118. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-13; PMID:18806780; http://dx.doi.org/10.1038/ nature07336.
119. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005; 48:1565-75; PMID:15986236; http://dx.doi.org/10.1007/s00125- 005-1831-2. (Pubitemid 41175510)